Literature DB >> 26184017

Perineurioma in the sigmoid colon diagnosed and treated by endoscopic resection.

Yasuteru Fujino1, Naoki Muguruma, Shinji Kitamura, Yasuhiro Mitsui, Tetsuo Kimura, Hiroshi Miyamoto, Hisanori Uehara, Koichi Kataoka, Tetsuji Takayama.   

Abstract

Perineuriomas are rare benign peripheral nerve sheath tumors in the gastrointestinal tract. We recently encountered a submucosal lesion in the sigmoid colon that was resected by endoscopic mucosal resection and was then diagnosed as perineurioma by immunohistochemistry. A 51-year-old female with a positive test for fecal occult blood was referred to our hospital for screening colonoscopy. Colonoscopy identified a submucosal lesion, approximately 15 mm in diameter, in the sigmoid colon. Endoscopic ultrasound showed a 15-mm tumor with a strong acoustic shadow. Endoscopic mucosal resection was performed in order to make a precise diagnosis as well as removal. The specimen revealed spindle cell proliferation without atypia, and immunostaining revealed that the spindle cells were positive for collagen type IV and glut-1, and the lesion was diagnosed as a colonic perineurioma with no malignancy. Gastroenterologists as well as pathologists should be aware of this type of submucosal lesion, and immunohistochemical evaluation is highly recommended when an unusual mesenchymal tumor is found.

Entities:  

Mesh:

Year:  2014        PMID: 26184017     DOI: 10.1007/s12328-014-0519-x

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  9 in total

1.  Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs).

Authors:  Shigeharu Miwa; Takahiko Nakajima; Yoshihiro Murai; Yasuo Takano; Toshiro Sugiyama
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

2.  Perineurioma of the stomach. A rare spindle cell neoplasm that should be distinguished from gastrointestinal stromal tumor.

Authors:  Abbas Agaimy; Peter H Wuensch
Journal:  Pathol Res Pract       Date:  2005       Impact factor: 3.250

Review 3.  Intestinal perineuriomas: clinicopathologic definition of a new anatomic subset in a series of 10 cases.

Authors:  Jason L Hornick; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2005-07       Impact factor: 6.394

4.  Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors--a clinicopathologic and immunohistochemical study of eighty-eight cases.

Authors:  M Miettinen; M Sarlomo-Rikala; L H Sobin
Journal:  Mod Pathol       Date:  2001-10       Impact factor: 7.842

Review 5.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

Review 6.  Gastrointestinal stromal tumors and other mesenchymal lesions of the gut.

Authors:  Joel K Greenson
Journal:  Mod Pathol       Date:  2003-04       Impact factor: 7.842

7.  Fibroblastic polyp of the colon and colonic perineurioma: 2 names for a single entity?

Authors:  Gabriel M Groisman; Sylvie Polak-Charcon
Journal:  Am J Surg Pathol       Date:  2008-07       Impact factor: 6.394

8.  DOG1 is useful for diagnosis of KIT-negative gastrointestinal stromal tumor of stomach.

Authors:  Takuya Wada; Satoshi Tanabe; Kenji Ishido; Katsuhiko Higuchi; Tohru Sasaki; Chikatoshi Katada; Mizutomo Azuma; Akira Naruke; Myunguchul Kim; Wasaburo Koizumi; Tetsuo Mikami
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

9.  Early colonic perineurioma: a report of 11 cases.

Authors:  Gabriel Groisman; Mary Amar; Meir Alona
Journal:  Int J Surg Pathol       Date:  2009-12-24       Impact factor: 1.271

  9 in total
  1 in total

Review 1.  Colonic perineurioma (benign fibroblastic polyp): case report and review of the literature.

Authors:  Abraham Christoffel van Wyk; Hennie van Zyl; Jonathan Rigby
Journal:  Diagn Pathol       Date:  2018-02-20       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.